Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Medicine, Refractory (planetary science), Hazard ratio, Chemotherapy, Surgery, and Cytarabine.
Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
Abstract CT184: Gilteritinib significantly prolongs overall survival in patients with <i>FLT3</i>-mutated (<i>FLT3</i>mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial